213 related articles for article (PubMed ID: 28927676)
1. A pilot study to expand treatment of chronic hepatitis C in resource-limited settings.
Mathur P; Comstock E; McSweegan E; Mercer N; Kumar NS; Kottilil S
Antiviral Res; 2017 Oct; 146():184-190. PubMed ID: 28927676
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hepatitis B and C in children.
El-Shabrawi M; Hassanin F
Minerva Pediatr; 2014 Oct; 66(5):473-89. PubMed ID: 25253190
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus: standard-of-care treatment.
Pawlotsky JM
Adv Pharmacol; 2013; 67():169-215. PubMed ID: 23886001
[TBL] [Abstract][Full Text] [Related]
4. Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010-2015.
Zimmermann R; Kollan C; Ingiliz P; Mauss S; Schmidt D; Bremer V
J Hepatol; 2017 Jul; 67(1):15-22. PubMed ID: 28189752
[TBL] [Abstract][Full Text] [Related]
5. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals.
Dobrowolska K; Brzdęk M; Rzymski P; Flisiak R; Pawłowska M; Janczura J; Brzdęk K; Zarębska-Michaluk D
Expert Opin Pharmacother; 2024 May; 25(7):833-852. PubMed ID: 38768013
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Virus: Current and Evolving Treatments for Genotype 4.
Asselah T; Bourlière M
Gastroenterol Clin North Am; 2015 Dec; 44(4):859-70. PubMed ID: 26600224
[TBL] [Abstract][Full Text] [Related]
7. The hepatitis C revolution part 1: antiviral treatment options.
Thiagarajan P; Ryder SD
Curr Opin Infect Dis; 2015 Dec; 28(6):563-71. PubMed ID: 26524328
[TBL] [Abstract][Full Text] [Related]
8. Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings.
Ford N; Swan T; Beyer P; Hirnschall G; Easterbrook P; Wiktor S
J Hepatol; 2014 Nov; 61(1 Suppl):S132-8. PubMed ID: 25443341
[TBL] [Abstract][Full Text] [Related]
9. New direct-acting antivirals' combination for the treatment of chronic hepatitis C.
Asselah T; Marcellin P
Liver Int; 2011 Jan; 31 Suppl 1():68-77. PubMed ID: 21205141
[TBL] [Abstract][Full Text] [Related]
10. Future perspectives: towards interferon-free regimens for HCV.
Gane E
Antivir Ther; 2012; 17(6 Pt B):1201-10. PubMed ID: 23186654
[TBL] [Abstract][Full Text] [Related]
11. Revolution in hepatitis C antiviral therapy.
Sadler MD; Lee SS
Br Med Bull; 2015 Mar; 113(1):31-44. PubMed ID: 25680808
[TBL] [Abstract][Full Text] [Related]
12. Pan-genotypic treatment regimens for hepatitis C virus: Advantages and disadvantages in high- and low-income regions.
Hézode C
J Viral Hepat; 2017 Feb; 24(2):92-101. PubMed ID: 27862695
[TBL] [Abstract][Full Text] [Related]
13. Improving access to the treatment of hepatitis C in low- and middle-income countries: evaluation of a patient assistance programme.
Ali S; Ur-Rehman T; Ali M; Haque S; Rasheed F; Lougher E; Nawaz MS; Paudyal V
Int J Clin Pharm; 2021 Aug; 43(4):958-968. PubMed ID: 33247820
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Sofosbuvir and Ribavirin for Eradicating Hepatitis C Virus in Renal Transplant Recipients in Pakistan: Where Resources Are Scarce.
Hanif FM; Laeeq SM; Mandhwani RK; Luck NH; Aziz T; Mehdi SH
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):63-67. PubMed ID: 28260436
[TBL] [Abstract][Full Text] [Related]
15. New Treatments Have Changed the Game: Hepatitis C Treatment in Primary Care.
Facente SN; Burk K; Eagen K; Mara ES; Smith AA; Lynch CS
Infect Dis Clin North Am; 2018 Jun; 32(2):313-322. PubMed ID: 29778258
[TBL] [Abstract][Full Text] [Related]
16. Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection.
Tang L; Ward H; Kattakuzhy S; Wilson E; Kottilil S
Expert Rev Gastroenterol Hepatol; 2016; 10(1):21-36. PubMed ID: 26558305
[TBL] [Abstract][Full Text] [Related]
17. [Chronic hepatitis C infection--eradication of the virus].
Ben Ari Z
Harefuah; 2014 Jul; 153(7):392-3, 433. PubMed ID: 25189028
[TBL] [Abstract][Full Text] [Related]
18. [Current status of treatment of chronic hepatitis C and related challenges in the "Pre-DAA Era" in China].
Hu P; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):869-873. PubMed ID: 27978936
[TBL] [Abstract][Full Text] [Related]
19. Shift in disparities in hepatitis C treatment from interferon to DAA era: A population-based cohort study.
Janjua NZ; Islam N; Wong J; Yoshida EM; Ramji A; Samji H; Butt ZA; Chong M; Cook D; Alvarez M; Darvishian M; Tyndall M; Krajden M
J Viral Hepat; 2017 Aug; 24(8):624-630. PubMed ID: 28130810
[TBL] [Abstract][Full Text] [Related]
20. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
